Literature DB >> 8185401

Prediction of surgical resectability in patients with hepatic colorectal metastases.

S B Vogel1, W E Drane, P R Ros, S R Kerns, K I Bland.   

Abstract

OBJECTIVE: To evaluate the efficacy of two distinct imaging techniques to predict, before operation, unresectability compared with standard computed tomographic scan (CT). SUMMARY
BACKGROUND: Accurate preoperative identification of the number, size, and location of hepatic lesions is crucial in planning hepatic resection for colorectal hepatic metastases. Although infusion-enhanced CT is the standard, its limitations are the imaging of relatively isodense and/or small (< 1 cm) lesions. The increased sensitivity of CT arterial portography (CTAP) may be offset by false-positive results caused by benign lesions and flow artifacts.
METHODS: Fifty-eight selected patients considered to be eligible for resection by standard CT had laparotomy. Before operation and in addition to CT, all patients had CT arterial portography and hepatic artery perfusion scintigraphy (HAPS) using radiolabeled macroaggregated albumin. Early studies showed an increased sensitivity for detecting small lesions using the invasive CTAP. Similarly, the HAPS study has detected malignant lesions not observed by standard CT.
RESULTS: Of 58 patients having laparotomy, 40 were resectable by either lobectomy (22) or trisegmentectomy (1) and the rest by single or multiple wedge resections. Eighteen patients could not be resected because of combined intra- and extrahepatic disease or the number and location of metastases. Standard CT detected 64% of all lesions (12% of lesions less than 1 cm). Unresectability was accurately predicted by CTAP and HAPS in 16 (88%) and 15 (83%), respectively, of the 18 patients considered ineligible for resection at laparotomy. Of the 40 patients who had resection for possible cure, CTAP and HAPS falsely predicted unresectability in 6 of 40 patients (15%) and in 10 of 40 patients (25%), respectively. The positive predictive value for unresectability of CTAP and HAPS was 73% and 60%, respectively. False-positive lesions after CTAP included hemangiomas, cysts, granulomas, and flow artifacts. False-positive HAPS lesions included patients in whom no tumor was found at surgery but with some identified by intraoperative ultrasound, blind biopsy, and blind resection.
CONCLUSIONS: False-positive results by HAPS and CTAP may limit the ability of these tests to accurately predict unresectability before operation and may deny patients the chance for surgical resection. The HAPS study does, however, detect small lesions not seen by CT or CTAP. Standard CT, although less sensitive, followed by surgery and intraoperative ultrasound, does not necessarily preclude patients who could be resected.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8185401      PMCID: PMC1243180          DOI: 10.1097/00000658-199405000-00009

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  25 in total

1.  Results of surgical excision of one to 13 hepatic metastases in 98 consecutive patients.

Authors:  J P Minton; W B Hamilton; A Sardi; C Nieroda; B Sickle-Santanello; P J O'Dwyer
Journal:  Arch Surg       Date:  1989-01

2.  Resection of liver metastases--when is it worthwhile?

Authors:  M A Adson
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

3.  Pattern of recurrence in liver resection for colorectal secondaries.

Authors:  H Ekberg; K G Tranberg; R Andersson; C Lundstedt; I Hägerstrand; J Ranstam; S Bengmark
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

4.  Liver resection for metastatic colorectal cancer.

Authors:  S Iwatsuki; C O Esquivel; R D Gordon; T E Starzl
Journal:  Surgery       Date:  1986-10       Impact factor: 3.982

5.  Major hepatic resection for metachronous metastases from colon cancer.

Authors:  B Cady; W V McDermott
Journal:  Ann Surg       Date:  1985-02       Impact factor: 12.969

6.  Preoperative determination of the resectability of hepatic tumors: efficacy of CT during arterial portography.

Authors:  W C Small; W B Mehard; L S Langmo; A P Dagher; E K Fishman; J P Heiken; M E Bernardino
Journal:  AJR Am J Roentgenol       Date:  1993-08       Impact factor: 3.959

7.  Hepatic resection for metastasis from colorectal cancer.

Authors:  F F Attiyeh; H J Wanebo; M W Stearns
Journal:  Dis Colon Rectum       Date:  1978-04       Impact factor: 4.585

Review 8.  Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases.

Authors: 
Journal:  Surgery       Date:  1988-03       Impact factor: 3.982

9.  Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach.

Authors:  F Bozzetti; R Doci; P Bignami; A Morabito; L Gennari
Journal:  Ann Surg       Date:  1987-03       Impact factor: 12.969

10.  Differentiation of hepatic metastases from hepatic hemangiomas and cysts by using MR imaging.

Authors:  J Wittenberg; D D Stark; B H Forman; P F Hahn; S Saini; R Weissleder; E Rummeny; J T Ferrucci
Journal:  AJR Am J Roentgenol       Date:  1988-07       Impact factor: 3.959

View more
  5 in total

1.  Role of computed tomographic arterial portography and intraoperative ultrasound in the evaluation of patients for resectability of hepatic lesions.

Authors:  R C Karl; J Choi; T J Yeatman; R A Clark
Journal:  J Gastrointest Surg       Date:  1997 Mar-Apr       Impact factor: 3.452

2.  The Precision of Hepatic Arterial Infusion Scintigraphy as a Quantitative Biomarker of Tumor Microvasculature.

Authors:  Mark Dunphy; Neeta Pandit-Taskar; Josef J Fox; Nancy Kemeny
Journal:  AJR Am J Roentgenol       Date:  2017-05-24       Impact factor: 3.959

3.  The role of positron emission tomography in colorectal carcinoma.

Authors:  Oussama M Nachar
Journal:  Ochsner J       Date:  2002

4.  Current value of intraoperative sonography during surgery for hepatic neoplasms.

Authors:  Johannes Zacherl; Christian Scheuba; Martin Imhof; Maximilian Zacherl; Friedrich Längle; Peter Pokieser; Fritz Wrba; Etienne Wenzl; Ferdinand Mühlbacher; Raimund Jakesz; Rudolf Steininger
Journal:  World J Surg       Date:  2002-02-14       Impact factor: 3.352

5.  Care of cancer patients with liver and bone metastases - the place of pharmaceutical care in a balanced plan, focused on the patient's needs and goals.

Authors:  Katarzyna A Rygiel; Mariola Drozd; Lucyna Bułaś
Journal:  Arch Med Sci       Date:  2016-06-13       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.